GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
Canadian Cancer Trials Group
Ohio State University Comprehensive Cancer Center
University of Pittsburgh
Hoffmann-La Roche
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
University Hospital, Lille
Rigshospitalet, Denmark
Maastricht University Medical Center
National Cancer Institute (NCI)
Stamford Pharmaceuticals, Inc.
Genentech, Inc.
Helsinki University Central Hospital
OHSU Knight Cancer Institute
Oslo University Hospital
The Netherlands Cancer Institute
OHSU Knight Cancer Institute
Jewish General Hospital
University Hospital Heidelberg
University Hospital, Lille
University Hospital, Bordeaux
SRH Wald-Klinikum Gera GmbH
University of Michigan Rogel Cancer Center
Samsung Medical Center
University of California, San Francisco
NYU College of Dentistry
UCSF Benioff Children's Hospital Oakland
National Cancer Institute (NCI)
UCSF Benioff Children's Hospital Oakland
Hoffmann-La Roche
Istituto Clinico Humanitas
Columbia University
University of Arizona
Hoffmann-La Roche
Mayo Clinic
Centre Leon Berard
Hoffmann-La Roche
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
Stanford University